5-(Pyridin-3-yl)-1,3,4-thiadiazol-2-amine

Catalog No. :
ACRFMS679
CAS No. :
68787-52-0
Molecular Formula :
C7H6N4S
Molecular Weight :
178.22

IUPAC Name:5-(pyridin-3-yl)-1,3,4-thiadiazol-2-amine

5-(Pyridin-3-yl)-1,3,4-thiadiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00Login to see priceInquiryInquiry
100mg95%$97.00Login to see priceInquiryInquiry
250mg95%$130.00Login to see priceInquiryInquiry
10g95%$670.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Pyridin-3-yl)-1,3,4-thiadiazol-2-amine
IUPAC Name5-(pyridin-3-yl)-1,3,4-thiadiazol-2-amine
MDL No.MFCD00469439
Molecular FormulaC7H6N4S
Molecular Weight178.22
SMILESNC1=NN=C(S1)C1=CC=CN=C1
InChI KeyMCYHQUZTYSVDHW-UHFFFAOYSA-N
SynonymDTXSID60276764 | MLS004820327 | NSC513815 | NSC-513815 | Cambridge id 5307245 | SR-01000512754-1 | 5-(3-pyridyl)-1,3,4-thiadiazol-2-amine | D91482 | 5-(3-Pyridinyl)-1,3,4-thiadiazol-2-amine, AldrichCPR | AKOS000305103 | HMS2411J13 | MLS000105664 | A9139 |
CAS No.68787-52-0
PubChem CID199037

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRFMS679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACARBN360 route compound structure diagram
    ACARBN360553-53-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRFMS679 route product structure diagram
    ACRFMS67968787-52-0
Inquiry

2. ACRFMS679 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIGKT215 route compound structure diagram
    ACIGKT21559-67-6 In Stock
  4. Then
  5. ACRFMS679 route product structure diagram
    ACRFMS67968787-52-0
Inquiry

Comments (0)